{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T21:20:40Z","timestamp":1775337640506,"version":"3.50.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hormones"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.14310\/horm.2002.1494","type":"journal-article","created":{"date-parts":[[2014,6,16]],"date-time":"2014-06-16T13:03:02Z","timestamp":1402923782000},"page":"407-412","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["L-carnitine treatment in a seriously ill cancer patient with severe hyperthyroidism"],"prefix":"10.1007","volume":"13","author":[{"given":"Rene","family":"Chee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravin","family":"Agah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Vita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Benvenga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,7,1]]},"reference":[{"key":"13030407_CR1","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S0140-6736(03)14073-1","volume":"9","author":"DS Cooper","year":"2003","unstructured":"Cooper DS, 2003 Hyperthyroidism. Lancet 9: 459\u2013468.","journal-title":"Lancet"},{"key":"13030407_CR2","unstructured":"Burch HB, Burman KD, Cooper DS, 2011 A 2011 survey of current practice in the management of Graves\u2019 disease. 81st Meeting of the American Thyroid Association, Indian Wells, Ca (Abstract O-184)."},{"key":"13030407_CR3","first-page":"679","volume-title":"Werner and Ingbar\u2019s, The Thyroid: A Fundamental and Clinical Text","author":"L Wartofsky","year":"2000","unstructured":"Wartofsky L, 2000 Thyrotoxic storm. In: Braverman LE, Utiger RD (eds), Werner and Ingbar\u2019s, The Thyroid: A Fundamental and Clinical Text. 8th ed. Philadelphia, Pennsylvania: Lippincott Williams & Wilkins, pp, 679\u2013684.","edition":"8"},{"key":"13030407_CR4","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1089\/thy.1996.6.659","volume":"6","author":"S Benvenga","year":"1996","unstructured":"Benvenga S, 1996 Benzodiazepine and remission of Graves\u2019 disease. Thyroid 6: 659\u2013660.","journal-title":"Thyroid"},{"key":"13030407_CR5","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/ncpendmet1006","volume":"5","author":"R Vita","year":"2009","unstructured":"Vita R, Lapa D, Vita G, et al, 2009 A patient with stress-related onset and exacerbations of Graves\u2019 disease. Nat Clin Pract Endocrinol Metab 5: 55\u201361.","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"13030407_CR6","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1365-2265.1993.tb00970.x","volume":"38","author":"BL Solomon","year":"1993","unstructured":"Solomon BL, Wartofsky L, Burman KD, 1993 Adjunctive cholestyramine therapy in thyrotoxicosis. Clin Endocrinol (Oxf) 38: 39\u201343.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"13030407_CR7","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1111\/j.1365-2265.2005.02249.x","volume":"62","author":"WC Tsai","year":"2005","unstructured":"Tsai WC, Pei D, Wang TF, et al, 2005 The effect of combination therapy with propylthiouracil and cholestyramine in the treatment of Graves\u2019 hyperthyroidism. Clin Endocrinol (Oxf) 62: 521\u2013524.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"13030407_CR8","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/BF03348036","volume":"21","author":"P Hagag","year":"1998","unstructured":"Hagag P, Nissenbaum H, Weiss M, 1998 Role of colestipol in the treatment of hyperthyroidism. J Endocrinol Invest 21: 725\u2013731.","journal-title":"J Endocrinol Invest"},{"key":"13030407_CR9","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1080\/07315724.2007.10719645","volume":"26","author":"AD Azezli","year":"2007","unstructured":"Azezli AD, Bayraktaroglu T, Orhan Y, 2007 The use of konjac glucomannan to lower serum thyroid hormones in hyperthyroidism. J Am Coll Nutr 26: 663\u2013668.","journal-title":"J Am Coll Nutr"},{"key":"13030407_CR10","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1089\/thy.2000.10.1043","volume":"10","author":"S Benvenga","year":"2000","unstructured":"Benvenga S, Lakshmanan M, Trimarchi F, 2000 Carnitine is a naturally occurring inhibitor of thyroid hormone nuclear uptake. Thyroid 10: 1043\u20131050.","journal-title":"Thyroid"},{"key":"13030407_CR11","doi-asserted-by":"publisher","first-page":"3579","DOI":"10.1210\/jcem.86.8.7747","volume":"86","author":"S Benvenga","year":"2001","unstructured":"Benvenga S, Ruggeri RM, Russo A, et al, 2001 Usefulness of L-carnitine, a naturally occurring inhibitor of thyroid hormone action, in iatrogenic hyperthyroidism: a randomized, double-blind, placebo-controlled clinical trial. J Clin Endocrinol Metab 86: 3579\u20133594.","journal-title":"J Clin Endocrinol Metab"},{"key":"13030407_CR12","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S0002-9343(03)00399-1","volume":"115","author":"S Benvenga","year":"2003","unstructured":"Benvenga S, Lapa D, Cannav\u00f2 S, et al, 2003 Successive thyroid storms treated with L-carnitine and low-dose methimazole. Am J Med 115: 417\u2013418.","journal-title":"Am J Med"},{"key":"13030407_CR13","first-page":"1211","volume":"130","author":"L Kragie","year":"1992","unstructured":"Kragie L, Doyle D, 1992 Benzodiazepines inhibit temperature-dependent L-[125I] triiodothyronine accumulation into human liver, human neuroblast, and rat pituitary cell lines. Endocrinology 130: 1211\u20131216.","journal-title":"Endocrinology"},{"key":"13030407_CR14","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.1158\/1078-0432.CCR-07-4619","volume":"14","author":"CS Diefenbach","year":"2008","unstructured":"Diefenbach CS, Gnjatic S, Sabbatini P, et al, 2008 Safety and immunogenicity study of NY-ESO-1b peptide and montanide ISA-51 vaccination of patients with epithelial ovarian cancer in high-risk first remission. Clin Cancer Res 14: 2740\u20132748.","journal-title":"Clin Cancer Res"},{"key":"13030407_CR15","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/978-1-4615-6005-0_6","volume-title":"Carnitine Today","author":"G Famularo","year":"1997","unstructured":"Famularo G, Matricardi F, Nucera E, et al 1997 Carnitine deficiency: primary and secondary syndromes. In: De Simone C, Famularo G (eds), Carnitine Today. Austin, Texas: RG Landes, pp, 119\u2013161."},{"key":"13030407_CR16","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1007\/s00134-011-2293-2","volume":"37","author":"A Kimmoun","year":"2011","unstructured":"Kimmoun A, Munagamage G, Dessalles N, et al, 2011 Unexpected awakening from comatose thyroid storm after a single intravenous injection of L-carnitine. Intensive Care Med 37: 1716\u20131717.","journal-title":"Intensive Care Med"}],"container-title":["Hormones"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.14310\/horm.2002.1494.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.14310\/horm.2002.1494\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.14310\/horm.2002.1494.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T15:38:09Z","timestamp":1739115489000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.14310\/horm.2002.1494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["13030407"],"URL":"https:\/\/doi.org\/10.14310\/horm.2002.1494","relation":{},"ISSN":["1109-3099","2520-8721"],"issn-type":[{"value":"1109-3099","type":"print"},{"value":"2520-8721","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"13 March 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}